Raw data supporting "Liraglutide exerts protective effects on MASLD independently of lipophagy, and the combination with kombucha presents no additional advantage".

This dataset contains all the experimental data used in the article "Liraglutide exerts protective effects on MASLD independently of lipophagy, and the combination with kombucha presents no additional advantage".The dataset includes:Body weight and composition data;Food and caloric intake data;Fasting blood glucose and oral glucose tolerance test (oGTT) results;Plasma lipid profile data;Hepatic biochemical parameters;Liver histology data;Western blotting analyses of LC3-II, p62, Atg7, and lysosomal acid lipase (LAL) expression;Hepatic LAL enzymatic activity assay data.These data support the investigation of potential synergistic effects between liraglutide and kombucha in the context of Metabolic dysfunction – associated steatotic liver disease (MASLD).